Carlsmed Appoints Richard Heppenstall as CFO
Carlsmed, a medical device company, appointed Richard Heppenstall as Chief Financial Officer on September 28, 2026. Heppenstall brings extensive experience in medtech finance and capital markets, including prior roles at multiple U.S.-listed and pre-IPO health tech firms.
51CFO view：CFO appointments at pre-IPO medtech firms trigger SEC scrutiny of executive bios in Form S-1: Prior IPO experience must be verifiable; SOX 404 implementation history, FDA-related expense accounting (e.g., clinical trial costs), and audit committee engagement records become material disclosure elements — not just credentials.
Carlsmed, a medical device company, appointed Richard Heppenstall as Chief Financial Officer on September 28, 2026. Heppenstall brings extensive experience in medtech finance and capital markets, including prior roles at multiple U.S.-listed and pre-IPO health tech firms.
Source：Google News · CFO 任命
Why this matters to your CFO search
Where this touches your finance hire
Every listing event changes what you need from a CFO. Start from the step you are actually at.
How is a US-listed CFO paid?
Base, equity incentive and listing-milestone bonus: structure and ranges.
Read →
What kind of CFO does a US IPO need?
S-1 / F-1 filing, US GAAP conversion, roadshow — the hard requirements.
Read →
Who runs finance through a SPAC merger?
De-SPAC files F-1 / 424(b); merger audit and disclosure cadence differ.
Read →